Statistics on Biotechnology Use  
Results by sector of operation
Company sector. Biotechnology results by main variables and no. of employees. 
Unidades: specified in variables

,Fewer than 250 employees,250 or more employees,Total,
No. of companies carrying out R&D in Biotechnology,1.061,73,1.133,
%Companies according to biotechnology used: Genetic code,30,50,32,
%Companies according to biotechnology used: Functional units,40,51,41,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,26,46,27,
%Companies according to biotechnology used: Bioprocesses,47,64,48,
%Companies according to biotechnology used: Sub-cellular organisms,8,20,8,
%Companies according to biotechnology used: Bio-computing,21,31,21,
%Companies according to biotechnology used: Nanobiotechnology,14,18,14,
%Companies according to biotechnology used: Other,13,10,13,
Companies in which biotechnology activities are: Main and/or exclusive,549,15,564,
Companies in which biotechnology activities are: A secondary line of business,193,19,212,
Companies in which biotechnology activities are: A tool necessary for production,319,38,358,
%Company by field(s) of ultimate application of biotechnology use: Human Health,50,51,50,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,20,1,19,
%Company by field(s) of ultimate application of biotechnology use: Food products,29,36,29,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,22,18,21,
%Company by field(s) of ultimate application of biotechnology use: Environment,13,11,13,
%Company by field(s) of ultimate application of biotechnology use: Industry,14,7,13,
Personnel in R&D in biotechnology (no. of persons),7.883,2.823,10.706,
Personnel in R&D in biotechnology (no. of persons): Researchers,4.706,1.521,6.227,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,3.177,1.302,4.479,
Personnel in R&D in biotechnology (no. of persons): women,4.068,1.727,5.795,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,2.417,852,3.269,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,1.652,875,2.527,
Personnel in R&D in biotechnology (FTE),5.599,2.117,4,7.716,4,
Personnel in R&D in biotechnology (FTE): Researchers,3.511,8,1.091,3,4.603,1,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.087,2,1.026,1,3.113,3,
Personnel in R&D in biotechnology (FTE): women,2.969,5,1.323,4,4.292,9,
Personnel in R&D in biotechnology (FTE): (women) Researchers,1.832,2,614,2,2.446,4,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.137,3,709,2,1.846,5,
Internal expenditure on R&D (thousands of euros),452.121,163.932,616.053,
1) By nature of the expense: Current expenses,413.906,160.340,574.245,
1.1) Remuneration to researchers,160.779,60.962,221.741,
1.2) Remuneration to technicians and assistants,61.960,40.504,102.464,
1.3) Other current expenses,191.167,58.874,250.041,
2) By nature of the expense: Capital expenses,38.215,3.593,41.808,
2.1) Land and buildings,4.988,371,5.359,
2.2) Equipment and instruments,26.997,2.493,29.489,
2.3) Acquisition of specific R&D software,1.716,590,2.306,
2.4) Otros productos de propiedad intelectual específicos para I+D,4.515,139,4.654,
1) By origin of the funds: National funds,388.127,123.833,511.960,
1.1) Own funds,294.928,87.407,382.335,
1.2) From companies,29.072,15.952,45.024,
1.3) Public Administration funds,60.976,11.410,72.387,
1.4) From Universities,363,0,363,
1.5) From non profit private institutions,2.788,9.064,11.851,
1) By origin of the funds: Foreign funds,63.994,40.100,104.093,
2.1) From EU programmes,18.363,3.462,21.825,
2.2) Other foreign funds,45.631,36.638,82.269,
Purchase of R&D services in biotechnology (thousands of euros),88.908,55.434,144.342,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,35.758,34.700,70.458,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,53.150,20.734,73.885,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,49,29,48,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,13,13,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,15,13,15,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,12,14,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,16,14,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,17,10,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,16,14,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,36,35,36,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,49,39,49,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,18,14,18,
% Companies that have requested biotechnology patents in Biotechnology,16,12,16,
Number of patents requested,570,63,633,
% Companies with income of an international origin related to biotechnological activities,24,2,20,7,24,
% Turnover representing income of an international origin related to biotechnological activities,6,1,0,9,1,4,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,37,3,75,7,57,3,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,62,7,24,3,42,7,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,96,3,69,4,82,3,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,2,4,29,4,16,5,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,1,0,9,1,
% Income of an international origin related with activities according to the classification: Other,0,2,0,3,0,3,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute